PRRT2 and cardiac hypertrophy: With respect to the heart, a number of studies have reported that PKC activation is associated with hypertrophy (Wang M. et al., 2020), dilated cardiomyopathy, ischemia–reperfusion injury (Hu et al., 2016), mitogen stimulation, and myocardial infarction (Wang et al., 2003).